Nordic BioVentures ApS: Financial statements 2024
CVR: 43852116
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic BioVentures ApS (CVR 43852116) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,381,891 and a net result of DKK 265,974 compared with DKK 1,470,607 the year before. That is a decrease of 27.4% compared with the year before. Equity in the 2024 report amounted to DKK 1,736,581. The solvency ratio was 83.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,381,891
- Profit/Loss
- DKK 265,974
- Equity
- DKK 1,736,581
- Total Assets
- DKK 2,079,949
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic BioVentures ApS has published its interim report for the period February 6, 2023 to December 31, 2023.
About Nordic BioVentures ApS
Nordic BioVentures ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Nordic BioVentures 1 AMBA and Nordic BioVentures AMBA. The management consists of Josephine Schrøder Warming and William Comstive Wright Nilsen. The company is owned by Warming Ventures ApS and Wright Ventures ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,512,110 and a net result of DKK -1,291,767 compared with DKK 265,974 the year before. Equity in the 2025 report amounted to DKK 444,815.
